Literature DB >> 11030154

MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression.

D Wang1, W Yang, J Du, M N Devalaraja, P Liang, K Matsumoto, K Tsubakimoto, T Endo, A Richmond.   

Abstract

The MGSA/GRO protein is endogenously expressed in almost 70% of the melanoma cell lines and tumors, but not in normal melanocytes. We have previously demonstrated that over-expression of human MGSA/GROalpha, beta or gamma in immortalized murine melanocytes (melan-a cells) enables these cells to form tumors in SCID and nude mice. To examine the possibility that the MGSA/GRO effect on melanocyte transformation requires expression of other genes, differential display was performed. One of the mRNA's identified in the screen as overexpressed in MGSA/GRO transformed melan-a clones was the newly described M-Ras or R-Ras3 gene, a member of the Ras gene superfamily. Over-expression of MGSA/GRO upregulates M-Ras expression at both the mRNA and protein levels, and this induction requires an intact glutamine-leucine-arginine (ELR)-motif in the MGSA/GRO protein. Western blot examination of Ras expression revealed that K- and N-Ras proteins are also elevated in MGSA/GRO-expressing melan-a clones, leading to an overall increase in the amount of activated Ras. MGSA/GRO-expressing melan-a clones exhibited enhanced AP-1 activity. The effects of MGSA/GRO on AP-1 activation could be mimicked by over-expression of wild-type M-Ras or a constitutively activated M-Ras mutant in control melan-a cells as monitored by an AP-1-luciferase reporter, while expression of a dominant negative M-Ras blocked AP-1-luciferase activity in MGSA/GRO-transformed melan-a clones. In the in vitro transformation assay, over-expression of M-Ras mimicked the effects of MGSA/GRO by inducing cellular transformation in control melan-a cells, while over-expression of dominant negative M-Ras in MGSA/GROalpha-expressing melan-a-6 cells blocked transformation. These data suggest that MGSA/GRO-mediated transformation requires Ras activation in melanocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11030154      PMCID: PMC2667445          DOI: 10.1038/sj.onc.1203820

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  56 in total

1.  Cell cycle-dependent activation of Ras.

Authors:  S J Taylor; D Shalloway
Journal:  Curr Biol       Date:  1996-12-01       Impact factor: 10.834

2.  Role of melanoma growth stimulatory activity (MGSA/gro) on keratinocyte function in wound healing.

Authors:  H O Rennekampff; J F Hansbrough; V Woods; C Doré; V Kiessig; J M Schröder
Journal:  Arch Dermatol Res       Date:  1997-03       Impact factor: 3.017

3.  Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases.

Authors:  C Knall; G S Worthen; G L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

4.  Cellular transformation and malignancy induced by ras require c-jun.

Authors:  R Johnson; B Spiegelman; D Hanahan; R Wisdom
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

5.  Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma.

Authors:  M Lopez-Ilasaca; P Crespo; P G Pellici; J S Gutkind; R Wetzker
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

6.  The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling.

Authors:  H S Huang; M Nagane; C K Klingbeil; H Lin; R Nishikawa; X D Ji; C M Huang; G N Gill; H S Wiley; W K Cavenee
Journal:  J Biol Chem       Date:  1997-01-31       Impact factor: 5.157

7.  High-level expression of H-ras and c-myc oncogenes in mycoplasma-mediated malignant cell transformation.

Authors:  B Zhang; J W Shih; D J Wear; S Tsai; S C Lo
Journal:  Proc Soc Exp Biol Med       Date:  1997-04

8.  Phosphatidylinositol 3-kinase is an early intermediate in the G beta gamma-mediated mitogen-activated protein kinase signaling pathway.

Authors:  B E Hawes; L M Luttrell; T van Biesen; R J Lefkowitz
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

9.  Constitutive and cytokine-induced expression of the melanoma growth stimulatory activity/GRO alpha gene requires both NF-kappa B and novel constitutive factors.

Authors:  L D Wood; A Richmond
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

10.  gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice.

Authors:  Y Cao; C Chen; J A Weatherbee; M Tsang; J Folkman
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  35 in total

1.  Clinical significance of serum expression of GROβ in esophageal squamous cell carcinoma.

Authors:  Qiao-Mei Dong; Jin-Qiang Zhang; Qian Li; Jacqueline C Bracher; Denver T Hendricks; Xiao-Hang Zhao
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

2.  The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.

Authors:  Gong Yang; Daniel G Rosen; Zhihong Zhang; Robert C Bast; Gordon B Mills; Justin A Colacino; Imelda Mercado-Uribe; Jinsong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

3.  PAK1 kinase is required for CXCL1-induced chemotaxis.

Authors:  Dingzhi Wang; Jiging Sai; Glendora Carter; Aristidis Sachpatzidis; Elias Lolis; Ann Richmond
Journal:  Biochemistry       Date:  2002-06-04       Impact factor: 3.162

4.  Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment.

Authors:  Anna E Vilgelm; C Andrew Johnson; Nripesh Prasad; Jinming Yang; Sheau-Chiann Chen; Gregory D Ayers; Jeff S Pawlikowski; Dayanidhi Raman; Jeffrey A Sosman; Mark Kelley; Jeffrey A Ecsedy; Yu Shyr; Shawn E Levy; Ann Richmond
Journal:  J Natl Cancer Inst       Date:  2015-12-30       Impact factor: 13.506

5.  CXCL1 expression is correlated with Snail expression and affects the prognosis of patients with gastric cancer.

Authors:  Zhen Xiang; DA-Ping Jiang; Guang-Gai Xia; Zhe-Wei Wei; Wei Chen; Yulong He; Chang-Hua Zhang
Journal:  Oncol Lett       Date:  2015-08-14       Impact factor: 2.967

6.  M-Ras induces Ral and JNK activation to regulate MEK/ERK-independent gene expression in MCF-7 breast cancer cells.

Authors:  Ariel F Castro; Tania Campos; Justin T Babcock; Marisol E Armijo; Alfonso Martínez-Conde; Roxana Pincheira; Lawrence A Quilliam
Journal:  J Cell Biochem       Date:  2012-04       Impact factor: 4.429

Review 7.  Nf-kappa B, chemokine gene transcription and tumour growth.

Authors:  Ann Richmond
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

8.  Association between CXCR2 and IL-22BP expression indicate a poor outcome for gastric adenocarcinoma progression.

Authors:  Shi Bin Yang; Fanghai Han; Jian Hai Wu; Zhi Zhao; Wenhua Zhan
Journal:  Oncol Lett       Date:  2016-06-28       Impact factor: 2.967

Review 9.  Role of CXCL1 in tumorigenesis of melanoma.

Authors:  Punita Dhawan; Ann Richmond
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

10.  Cell surface heparan sulfate participates in CXCL1-induced signaling.

Authors:  Dingzhi Wang; Jiqing Sai; Ann Richmond
Journal:  Biochemistry       Date:  2003-02-04       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.